FIELD: medicine.
SUBSTANCE: proposed group of inventions relates to medicine. Disclosed are methods of detecting the presence in a biological fluid sample of a DNA base associated with an extracellular nucleosome, method for assessing an animal subject or individual with respect to suitability for therapeutic treatment, method of observing treatment of an animal subject or human and use of a DNA base associated with an extracellular nucleosome as a biomarker in a biological fluid sample for diagnosing cancer, wherein the DNA base is selected from 5-methylcytosine or 5-hydroxymethylcytosine.
EFFECT: proposed group of inventions provides higher clinical sensitivity of cancer diagnosis in animal subject or person.
17 cl, 21 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETECTING NUCLEOSOMES CONTAINING HISTONE VERSIONS | 2012 |
|
RU2716494C2 |
| METHOD FOR NUCLEOSOMES ADDUCTS DETECTION | 2012 |
|
RU2634266C2 |
| METHOD AND DEVICE FOR BLOOD PURIFICATION FROM FREE-CIRCULATING DNA | 2018 |
|
RU2779220C2 |
| METHOD FOR SCREENING OF ANTITUMOR PREPARATIONS - PARP1 INHIBITORS BASED ON BIOCHEMICAL METHODS OF ANALYSIS | 2015 |
|
RU2639535C2 |
| NOVEL TUMOUR BIOMARKER | 2010 |
|
RU2567005C2 |
| HISTONES AND/OR proADM AS MARKERS TESTIFYING ABOUT ORGAN DYSFUNCTION | 2017 |
|
RU2764766C2 |
| EXO-SOMATIC BIOMARKERS | 2015 |
|
RU2712223C2 |
| HISTONES AND/OR proADM AS MARKERS INDICATING ADVERSE EVENT | 2017 |
|
RU2765212C2 |
| CHROMOGRANIN A AS MARKER OF BLADDER CANCER | 2017 |
|
RU2785737C2 |
| TEST-SYSTEM FOR CHEMICAL COMPOUNDS SCREENING FOR INHIBITING ACTIVITY AGAINST PARP-1 | 2016 |
|
RU2649767C1 |
